The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy?
Manikandan Muthu1, Sechul Chun1, Judy Gopal1
1Department of Environmental Health Sciences, Konkuk University, Seoul 143-701, Korea.
Abstract:
Despite multitudes of reports on cancer remedies available, we are far from being able to declare that we have arrived at that defining anti-cancer therapy. In recent decades, researchers have been looking into the possibility of enhancing cell death-related signaling pathways in cancer cells using pro-apoptotic proteins. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and Mu-2/AP1M2 domain containing, death-inducing (MUDENG, MuD) have been established for their ability to bring about cell death specifically in cancer cells. Targeted cell death is a very attractive term when it comes to cancer, since most therapies also affect normal cells. In this direction TRAIL has made noteworthy progress. This review briefly sums up what has been done using TRAIL in cancer therapeutics. The importance of MuD and what has been achieved thus far through MuD and the need to widen and concentrate on applicational aspects of MuD has been highlighted. This has been suggested as the future perspective of MuD towards prospective progress in cancer research.
Insights
Researchers are exploring pro-apoptotic proteins like TRAIL and MuD to induce targeted cancer cell death. This review highlights TRAIL
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Current cancer therapies often lack specificity, affecting normal cells alongside cancerous ones.
- Targeting cancer cell death pathways offers a promising therapeutic strategy.
- Pro-apoptotic proteins are being investigated to enhance cancer cell demise.
Purpose of the Study:
- To review the therapeutic applications of Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL) in cancer treatment.
- To highlight the significance of Mu-2/AP1M2 domain containing, death-inducing (MuD) protein in cancer research.
- To discuss current achievements and future perspectives for MuD's application in cancer therapy.
Main Methods:
- Literature review of studies involving TRAIL in cancer therapeutics.
- Analysis of research progress and achievements related to MuD protein.
- Exploration of the potential applicational aspects of MuD.
Main Results:
- TRAIL has demonstrated notable progress in cancer therapeutics, inducing targeted cell death.
- MuD has shown potential for inducing cancer cell death, though its application requires further development.
- The review emphasizes the need to expand research on MuD's applicational aspects.
Conclusions:
- TRAIL represents a significant advancement in targeted cancer therapy.
- MuD holds promise as a future anti-cancer agent, necessitating focused research on its practical applications.
- Further investigation into MuD's therapeutic potential is crucial for advancing cancer research.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:38Mitogens and the Cell Cycle
02:23Abnormal Proliferation
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:27Tumor Immunotherapy
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...